Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients

[1] Badve S(2011)Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists Mod Pathol 24 157-167

[2] Dabbs DJ(2009)Triple-negative/basal-like breast cancer: review Pathology 41 40-47

[3] Schnitt SJ(2007)Prognostic markers in triple-negative breast cancer Cancer 109 25-32

[4] Baehner SL(2011)Triple-negative breast cancer: an unmet medical need Oncologist 16 1-11

[5] Decker T(2011)Therapeutic targets in triple negative breast cancer-where are we now? Recent Pat Anticancer Drug Discov 6 196-209

[6] Eusebi V(2011)Triple negative breast cancer: unmet medical needs Breast Cancer Res Treat 125 627-636

[7] Fox SB(2012)Neoadjuvant chemotherapy in the very young breast cancer patients Cancer Res 72 S3-1 (SABCS 2012)-vi12

[8] Ichihara S(2012)Triple-negative breast cancer: epidemiological considerations and recommendations Ann Oncol 23 vi7-4380

[9] Jacquemier J(2011)Characteristics of triple-negative breast cancer in patients with a BRCA 1 mutation: results from a population-based study of young women J Clin Oncol 29 4373-140

[10] Lakhani SR(1987)Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 8 138-11

[1] Badve S(2011)Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists Mod Pathol 24 157-167

[2] Dabbs DJ(2009)Triple-negative/basal-like breast cancer: review Pathology 41 40-47

[3] Schnitt SJ(2007)Prognostic markers in triple-negative breast cancer Cancer 109 25-32

[4] Baehner SL(2011)Triple-negative breast cancer: an unmet medical need Oncologist 16 1-11

[5] Decker T(2011)Therapeutic targets in triple negative breast cancer-where are we now? Recent Pat Anticancer Drug Discov 6 196-209

[6] Eusebi V(2011)Triple negative breast cancer: unmet medical needs Breast Cancer Res Treat 125 627-636

[7] Fox SB(2012)Neoadjuvant chemotherapy in the very young breast cancer patients Cancer Res 72 S3-1 (SABCS 2012)-vi12

[8] Ichihara S(2012)Triple-negative breast cancer: epidemiological considerations and recommendations Ann Oncol 23 vi7-4380

[9] Jacquemier J(2011)Characteristics of triple-negative breast cancer in patients with a BRCA 1 mutation: results from a population-based study of young women J Clin Oncol 29 4373-140

[10] Lakhani SR(1987)Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 8 138-11